{"database": "lobbying", "table": "lobbying_activities", "rows": [[1690924, "ec3377a4-9715-42e9-a522-7e6d8e5c8d74", "Q2", "ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC)", 1466, "ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC)", 2015, "second_quarter", "MED", "AACC contacted House and Senate staff and legislators to express concerns about ongoing efforts to expand Food and Drug Administration oversight to laboratory developed tests.  Currently LDTs are regulated by the Centers for Medicare and Medicaid Services.\n\nAACC also contacted House and Senate staff and legislators to discuss the harmonization of clinical laboratory test results.  The Accompanying Language to the Consolidated and Further Continuing Appropriations Act of 2015 included a recommendation under the Centers for Disease Control Prevention Environmental Health section that encourages CDC to work with the private sector in promoting harmonization.  AACC mentioned its intent to develop and circulate a legislative proposal to satisfy that recommendation. \n\nAACC also expressed its support for federal efforts to advance personalized medicine with House, Senate and White House personnel.", "Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,SENATE", null, 40000, 0, 0, "2015-07-06T16:24:44.520000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1690924"], "units": {}, "query_ms": 8.277526940219104, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}